BIEPZO
DEAD

Serial Number

79391048

Owner

SAMSUNG BIOEPIS CO., LTD.

Filing Date

Jan 22, 2024

Add to watchlist:

No watchlists yet
View on USPTO

BIEPZO Trademark

Serial Number: 79391048

BIEPZO is a trademark filed by SAMSUNG BIOEPIS CO., LTD. on January 22, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

SAMSUNG BIOEPIS CO., LTD. (58 trademarks)

76, Songdogyoyuk-ro, Yeonsu-gu

Entity Type: 03

Trademark Details

Filing Date

January 22, 2024

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory, respiratory, and transplantation-related diseases and disorders; pharmaceutical preparations for the treatment of generalized myasthenia gravis; dietary supplements; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the treatment of osteoporosis; human vaccine preparations; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations, namely, pharmaceutical preparations, biological formulations, biological preparations, antibody formulations and protein formulations for immunoregulation and for treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; pharmaceutical preparations for the treatment of bone fractures; pharmaceutical preparations for the prevention of diseases of the musculoskeletal system; nutraceuticals for medical purposes; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for tumor treatment; preparations for treatment of cancer; preparations for treatment of tumour diseases; preparations for treatment of multiple myeloma; pharmaceutical preparations for the treatment of skeletal diseases; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of solid cancer

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 12, 2026 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Jan 26, 2026 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 25, 2026 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 22, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 6, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 6, 2025 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jan 25, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 25, 2025 ABN2
REFUSAL PROCESSED BY IB
Jul 28, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 11, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jul 11, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 21, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jun 20, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 7, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 24, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 14, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 13, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 7, 2024 REPR